ESC Premium Access

Mortality and morbidity in heart failure patients exposed to Digoxin: comprehensive data according to ejection fraction and atrial fibrillation in 41881 patients from the Swedish Heart Failure Registr

Congress Presentation

About the speaker

Associate Professor Gianluigi Savarese

Karolinska Institute, Stockholm (Sweden)
43 presentations

4 more presentations in this session

State of the art in drug therapy in chronic heart failure.

Speaker: Professor D. van Veldhuisen (Groningen, NL)


Beneficial effect of aldosterone antagonism on exercise tolerance in heart failure with preserved ejection fraction- SpironolacTone in myocaRdial dysfUnCTion with redUced exeRcisE capacity (STRUCTURE)

Speaker: Professor W. Kosmala (Wroclaw, PL)


Risk of long-term mortality associated with diuretic treatment in 17,519 heart failure outpatients was increased with 42% after adjustment for MAGGIC mortality risk predictors

Speaker: Doctor P. Paren (Gothenburg, SE)


Future direction for research in drug therapy.

Speaker: Professor J. Teerlink (San Francisco, US)


Access the full session

Drug therapy in heart failure

Speakers: Associate Professor G. Savarese, Professor D. van Veldhuisen, Professor W. Kosmala, Doctor P. Paren, Professor J. Teerlink

About the event


ESC Congress 2016

27 August - 31 August 2016

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb